In-vitro and in-vivo anti-inflammatory and antinociceptive effects of the methanol extract of the roots of Morinda officinalis

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 5, 2005, Pages 607-615

  Kim, In Tae ^a   Park, Hee Juhn ^d   Nam, Jung Hwan ^d   Park, Young Mi ^a   Won, Jong Heon ^a   Choi, Jongwon ^c   Choe, Bong Keun ^b   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Kyungsung University   (South Korea)

^d Sangji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CARRAGEENAN; CYCLOOXYGENASE 2; I KAPPA B; IBUPROFEN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHANOL; MORINDA OFFICINALIS EXTRACT; MORPHINE SULFATE; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CELL LINE; CELL STIMULATION; CELL STRAIN RAW 264.7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; EDEMA; HOT PLATE TEST; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MEDICINAL PLANT; MORINDA OFFICINALIS; MOUSE; NONHUMAN; PLANT ROOT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RUBIACEAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM-BINDING PROTEINS; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; DINOPROSTONE; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; METHANOL; MICE; MICE, INBRED ICR; MORINDA; NERVE TISSUE PROTEINS; NF-KAPPA B; NITRIC OXIDE; PAIN; PLANT EXTRACTS; PLANT ROOTS; RNA, MESSENGER; SYNAPTOTAGMIN I; SYNAPTOTAGMINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17644381896     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055902     Document Type: Article

References (34)

1. Baeuerle, P. A. (1998) IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 95: 729-731
2. Baeuerle, P. A., Baltimore, D. (1996) NF-kappa B: ten years after. Cell 87: 13-20
3. Barnes, P. J., Karin, M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071
4. Boros, C. A., Stermitz, F. R. (1990) Iridoids. An updated review. J. Nat. Prod. 53: 1055-1147
5. Brown, K., Gerberger, S., Carlson, L., Franzoso, G., Siebenlist, U. (1995) Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488
6. Cimanga, K., Hermans, N., Apers, S., Van Miert, S., Van den Heuvel, H., Claeys, M., Pieters, L., Vlietinck, A. (2003) Complement-inhibiting iridoids from Morinda moindoides. J. Nat. Prod. 66: 97-102
7. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li., Suyang, H., Ghosh, S., Karin, M. (1996) Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 4: 1295-1304
8. Eddy, N. B., Leimback, D. (1953) Synthetic analgesics. II. Dithienbutenyl- and dithienbutenylamines. J. Pharmacol. Exp. Ther. 107: 385-393
9. th edn. Saunders, Edinburgh
10. Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., Fitzgerald, G. A. (1991) Human platelet/erythroleukemia cell prostaglandin G/H synthase; cDNA cloning, expression and gene chromosomal assignment. FASEB J. 5: 2304-2312
11. Han, D. S. (2001) Pharmacognosy. Dongmyung, Seoul
12. Hayashi, G., Takemori, A. E. (1971) The type of analgesic-receptor interaction involved in certain analgesic assays. Eur. J. Pharmacol. 16: 63-66
13. Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., Gerhauser, C. (2001) Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276: 32 008-32 015.
14. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y., Baeuerle, P. A. (1993) Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365: 182-185
15. Hinz, B., Brune, K. (2002) Cyclooxygenase: 2-10 years later. Biochem. Biophys. Res. Commun. 300: 367-375
16. Ignarro, L. J. (2002) Nitric oxide as a unique signaling molecule in the vascular system; a historical overview. J. Physiol. Pharmacol. 53: 503-514
17. 2 production from murine macrophage RAW 264.7 cells. Biol. Pharm. Bull. 26: 481-486
18. Koppert, W., Wehrfritz, A., Korber, N., Sittl, R., Albrecht, S., Schuttler, J., Schmelz, M. (2004) The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 108: 148-153
19. Lappas, M., Permezel, M., Georgiou, H. M., Rice, G. E. (2002) Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 67: 668-673
20. Lee, J. H., Ku, C. H., Baek, N. I., Kim, S. H., Park, H. W., Kim, D. K. (2004) Phytochemical constituents from Diodia teres. Arch. Pharm. Res. 27: 40-43
21. Ling, S. K., Komorita, A., Fujioka, T., Mihashi, K., Kouno, I. (2002) Sulfur-contaning bis-iridoid glucosides and iridoid glucosides from Saprosmas cortechinii. J. Nat. Prod. 65: 656-660
22. Michel, T., Feron, O. (1997) Nitric oxide synthases: which, where, how and why? J. Clin. Invest. 100: 2146-2152
23. O'Conell, M. A., Benett, B. L., Mercurio, F., Mainning, A. M., Markman, N. (1998) Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 46: 30 410-30 414
24. Prescott, S. M., Ritzpatrick, F. A. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta 1470: M69-M78
25. 2 formation. J. Biol. Chem. 271: 31 496-31 501
26. Salvemini, D., Ischiropoulos, H., Cuzzocrea, S. (2003) Roles of nitric oxide and superoxide in inflammation. Methods Mol. Biol. 225: 291-303
27. Sang, S., Cheng, X., Zhu, N., Wang, M., Jhoo, J. W., Stark, R. E., Badmaev, V., Ghai, G., Rosen, R. T., Ho, C. T. (2001) Iridoid glycosides from the leaves of Morinda citrifolia. J. Nat. Prod. 64: 799-800
28. Schmedtje, J. F. Jr, Ji, Y. S., Liu, W. L., DuBois, R. N., Runge, M. S. (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272: 601-608
29. Subbaranaiah, K., Dannenberg, A. J. (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24: 96-102
30. Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K., Lee, S. S. (2001) Molecular mechanism underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481: 243-268
31. West, N. E., Qian, H., Guzik, T. J., Black, E., Cai, S., George, S. E., Channon, K. M. (2001) Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling; effects in vascular smooth muscle cell differentiation and superoxide production. Circulation 104: 1526-1532
32. Xie, Q. W., Kashiwabara, Y., Nathan, C. (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708
33. Xie, W., Merrill, J. R., Bradshaw, W. S., Simmons, D. L. (1993) Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch. Biochem. Biophys. 300: 247-252
34. 2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study. Pain 67: 345-354